Showing results (141-150 of 759) with videos related to
Sort By:
Pageof 76
Kidney International|October 16, 2008
Candesartan and renal protection: more than blocking angiotensin type 1 receptor?Daniela Macconi, Giuseppe RemuzziTrends in Endocrinology and Metabolism: TEM|October 11, 2012
Renal progenitors in non-diabetic and diabetic nephropathiesPaola Romagnani, Giuseppe RemuzziNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 21, 2023
C3G and Ig-MPGN-treatment standardMarina Noris, Giuseppe RemuzziDiabetes|June 5, 2013
ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapyErica Rurali, Marina Noris, Antonietta Chianca, et al.Eclinicalmedicine|January 3, 2022
Fresh lemon juice supplementation for the prevention of recurrent stones in calcium oxalate nephrolithiasis: A pragmatic, prospective, randomised, open, blinded endpoint (PROBE) trialPiero Ruggenenti, Maria Rosa Caruso, Monica Cortinovis, et al.Diabetes Research and Clinical Practice|May 25, 2023
MAFLD and glomerular hyperfiltration in subjects with prediabetes, visceral obesity and "preserved" kidney function: A cross-sectional studyAneliya Parvanova, Manuela Abbate, Aina Maria Yañez, et al.Annali Dell'Istituto Superiore Di Sanita|March 25, 2011
Why rare diseases?Giuseppe Remuzzi, Arrigo SchieppatiCurrent Opinion in Nephrology and Hypertension|October 10, 2018
Mesenchymal stromal cells in kidney transplantationFederica Casiraghi, Giuseppe RemuzziKidney International. Supplement|August 20, 2005
Chronic renal diseases as a public health problem: epidemiology, social, and economic implicationsArrigo Schieppati, Giuseppe RemuzziKidney International|October 31, 2020
Atypical hemolytic uremic syndrome associated with a factor B genetic variant and fluid-phase complement activation: an exception to the rule?Marina Noris, Giuseppe RemuzziPageof 76